Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
Stefan Schreiber, Shomron Ben‐Horin, Jarosław Leszczyszyn, Robert Dudkowiak, Adi Lahat, Beata Gawdis-Wojnarska, Aldis Puķītis, M. Horyński, Katalin Farkas, Jarosław Kierkuś, Maciej Kowalski, Sang Joon Lee, Sung Hyun Kim, Jee Hye Suh, Mi Rim Kim, Seul Gi Lee, Byong Duk Ye, Walter Reinisch
Topics & Concepts
MedicineClinical endpointRandomized controlled trialInfliximabUlcerative colitisInflammatory bowel diseaseInternal medicineGastroenterologyConfidence intervalCrohn's diseasePharmacokineticsRandomizationColonoscopyNuclear medicineSurgeryColorectal cancerDiseaseCancerBiosimilars and Bioanalytical MethodsInflammatory Bowel DiseaseMicroscopic Colitis